Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld (tixagevimab [...]
Key Points Question How do patients with multiple sclerosis (MS) who have COVID-19 fare and are there patient and disease [...]
People with MS have asked for guidance on the use of Disease Modifying Therapies (DMTs) during the COVID-19 pandemic. There are numerous [...]
